Funding News Edition: June 02, 2021 See more articles in this edition
Investigators conducting coronavirus-related research should attend the NIH Summit on Anti-SARS-CoV-2 Antibodies for Treatment and Prevention of COVID-19: Lessons Learned and Remaining Questions on Tuesday, June 15, from 11 a.m. to 4 p.m. Eastern Time. Presenters will summarize current knowledge and lessons learned on clinically relevant anti-SARS-CoV-2 antibodies for the treatment or prevention of COVID-19 and identify key unanswered scientific questions for clinical development and implementation.
You don’t need to preregister; the videocast linked above will stream the event live.
The Summit will open with remarks from NIH Director Dr. Francis Collins, Acting FDA Commissioner Dr. Janet Woodcock, and NIAID Director Dr. Anthony Fauci, proceeded by presentations on the state of the science. Three sessions will follow from there:
- Mechanisms of Action of Functional Antibodies That Neutralize SARS-CoV-2 or Eliminate SARS-CoV-2 Infected Cells
- Preclinical Delivery, Pharmacology, and Efficacy of Anti-SARS-CoV-2 Antibodies
- Real-World Clinical Use of Anti-SARS-CoV-2 Antibodies
Each session will feature a brief presentation and moderated panel discussion to address design, development, and real-world use of anti-SARS-CoV-2 antibodies.
See the Summit Agenda for complete details.